2 High-Yield Dividend Stocks to Buy and 1 to Avoid
Key PointsPfizer's free cash flow is not covering its dividend, and the company faces a patent cliff.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.